Wykłady 2018


Prof. Osborn Almeida (Max Planck Institute of Psychiatry)

Tytuł wykładu: Stress and Mental Healthspan


Prof. Marcel Hibert (Laboratoire d’Innovation Thérapeutique, Faculty of Pharmacy, University of Strasbourg, Francja)

Tytuł wykładu: In the shadow of Eros: medicinal chemistry of love and autism?

Prof. Martin Schwab (Institute of Regenerative Medicine (IREM), University of Zurich and Dept. of Health Sciences and Technology, ETH Zurich)

Tytuł wykładu: Neurobiological mechanisms of functional recovery after spinal cord injury or stroke; the long way from the lab bench to the clinic with a neurite growth enhancing therapy


Prof. Sabatino Maione (Department of Experimental Medicine, Division of Pharmacology, University of Campania "L. Vanvitelli", Neapol, Włochy)

Tytuł wykładu: N-acylethanolamines modulate pain transmission and the associated maladaptive neuroplasticity


Dr  Eliyahu Dremencov (Institute of Molecular Physiology and Genetics, Centre for Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratysława, Słowacja)
Tytuł wykładu: The effect of prenatal immune challenge in rats on the maternal-care behavior and on monoamine neurotransmission in offsprings

Prof. Yousef Tizabi (Department of Pharmacology, Howard University College of Medicine, Washington, USA)
Tytuł wykładu: In Search of Novel Antidepressants and/or Neuroprotectants

Prof. Robert J. Lefkowitz, MD (Duke University Medical Center, USA)
Tytuł wykładu: Seven transmembrane receptors

Prof. dr hab. Daniel Svozil (University of Chemical Technology, Department of Informatics and Chemistry, Praga)
Tytuł wykładu: Molecular morphing - artificial non-intelligent way for de novo molecular design


Dr Dasiel O. Borroto Escuela (Department of Neuroscience, Karolinska Institutet, Sztokholm)  
Tytuł wykładu:  Allosteric receptor-receptor interactions in homo-and heteroreceptor complexes give a new dimension to the understanding of substance use disorder